Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
CARDIOVASCULAR PREVENTION / LETTER TO THE EDITOR
Beyond Traditional Lipid Markers: Low-density Lipoprotein Cholesterol with Apolipoprotein B Ratio – a Novel Biomarker for Sarcopenia?
1
Grigore T. Popa University of Medicine and Pharmacy, Romania
2
Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Poland
Submission date: 2026-06-28
Acceptance date: 2026-06-28
Online publication date: 2026-06-28
Corresponding author
Maciej Banach
Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland
Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland
RELATED ARTICLE
TOPICS
REFERENCES (14)
1.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019; 48 (1): 16-31.
2.
Yu M, Ge L, Fu C, Zhao R. Unraveling the metabolic pathways between atherosclerosis and sarcopenia. Front Endocrinol (Lausanne), 2026; 16: 1762825.
3.
Bielecka-Dabrowa A, Banach M, Wittczak A, Cicero AFG, Kallel A, et al. The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper. Arch Med Sci, 2023;19(4):841-864.
4.
Bielecka-Dabrowa A, Fabis J, Mikhailidis DP, von Haehling S, Sahebkar A, Rysz J, Banach M. Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure. Trends Pharmacol Sci, 2018; 39 (4): 331-353.
5.
Kim HS, Cho YK, Kim MJ, Kim EH, Lee MJ, et al. Association between atherogenic dyslipidemia and muscle quality defined by myosteatosis. Front Endocrinol (Lausanne), 2024; 15: 1327522.
6.
Jiang Y, Xu B, Zhang K, Zhu W, Lian X, et al. The association of lipid metabolism and sarcopenia among older patients: a cross-sectional study. Sci Rep. 2023; 13 (1): 17538.
7.
Yang X, Zhang Z. The association of low-density lipoprotein cholesterol with apolipoprotein B ratio and sarcopenia: a cross-sectional study. Archives of Medical Science, 2026; 22 (3). doi:10.5114/aoms/214480.
8.
Gong H, Liu Y, Lyu X, Dong L, Zhang X. Lipoprotein subfractions in patients with sarcopenia and their relevance to skeletal muscle mass and function. Exp Gerontol, 2022; 159: 111668.
9.
Sousa-Victor P, Garcia-Prat L, Munoz-Canoves P. Control of satellite cell function in muscle regeneration and its disruption in ageing. Nat Rev Mol Cell Biol, 2022; 23: 204-26.
10.
Solnica B, Sygitowicz G, Sitkiewicz D, Jóźwiak J, Kasperczyk S, et al. 2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders. Arch Med Sci, 2024; 20 (2): 357-374.
11.
Sun Y, Liu BW, Zhang X, Yin FZ. Relationships Between the Apolipoprotein Levels and Sarcopenia in Inpatients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Diabetes Metab Syndr Obes, 2024; 17: 2085-2094.
12.
Boren J, Chapman MJ, Krauss RM, et al. Low-density lipo- proteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J, 2020; 41: 2313-30.
13.
Ceasovschih A, Balta A, Aldeen ES, Bianconi V, Barkas F, et al. Sodium-glucose cotransporter 2 inhibitors and atherosclerosis. Am J Prev Cardiol. 2025; 23: 101061.
14.
Toth PP, Banach M; International Lipid Expert Panel (ILEP). 2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk? Arch Med Sci. 2025; 21 (6): 2229-2245.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
